Chronic Congestive Heart Failure
Conditions
Brief summary
Patients suffering from Chronic Heart Failure (CHF) are hospitalized for acute heart failure (AHF) several times a year. Currently, we have no method for prediction of future developments of AHF. In our center we have investigated the monitoring of lung impedence as a predictor for future deterioration. It was found that a decrease in lung impedence of more than 15% from normal value predicts AHF development with sensitivity of 98%. In this study we try to prove the hypothesis that preventive treatment according to lung impedence value may prevent future hospitalizations for AHF and improve clinical outcome. Patients recruited by year: 2011 - 50; 2012 - 25; 2013 - 35; 2014 - 30; 2015 - 50; 2016 - 5
Interventions
OTHERLung impedence-guided treatment
One hundred fifty patients with CHF will be treated according to common practice and values of lung impedance
Sponsors
Hillel Yaffe Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients suffering from CHF, NYHA II-IV class * LV lower than 35% to LV lower than 45%
Exclusion criteria
* Patients with additional disease with life-expectancy of less than 2 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of hospitalization for acute heart failure | Five years |
Secondary
| Measure | Time frame |
|---|---|
| Improved clinical outcome for CHF patients | Five years |
Countries
Israel
Outcome results
None listed